Effects of Varenicline in Heavy Drinking Smokers

NCT02488889 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2018-06-01

No results posted yet for this study

Summary

This laboratory study will examine if varenicline can reduce alcohol-induced smoking lapse in heavy drinking smokers.

Conditions

  • Cigarette Smoking
  • Alcohol Consumption

Interventions

DRUG

Varenicline

DRUG

Placebo pill (for varenicline)

DRUG

Alcohol

DRUG

placebo beverage (for alcohol)

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-07-17
Completion
2016-07-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02488889 on ClinicalTrials.gov